June 15, 2022
Author(s)
Sarah Inwood, Linhua Tian, Kirsten Parratt, Samantha Maragh, Lili Wang
CRISPR/Cas9, one of the most commonly used genome editing systems, has been used for production of protein, cell and gene therapies. While an exciting tool, there is not a lot of long-term data about its genomic and phenotypic stability and off-target